Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Equity / Common Shares, $0.01 par value
-
Shares outstanding
-
28,862,386
-
Number of holders
-
41
-
Total 13F shares, excl. options
-
2,171,425
-
Shares change
-
-54,580
-
Total reported value, excl. options
-
$40,653,000
-
Value change
-
-$924,995
-
Number of buys
-
20
-
Number of sells
-
-23
-
Price
-
$18.73
Significant Holders of abrdn Life Sciences Investors - Common Shares, $0.01 par value (HQL) as of Q3 2016
48 filings reported holding HQL - abrdn Life Sciences Investors - Common Shares, $0.01 par value as of Q3 2016.
abrdn Life Sciences Investors - Common Shares, $0.01 par value (HQL) has 41 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2,171,425 shares
of 28,862,386 outstanding shares and own 7.5% of the company stock.
Largest 10 shareholders include MORGAN STANLEY (544,546 shares), NEEDHAM INVESTMENT MANAGEMENT LLC (524,335 shares), WELLS FARGO & COMPANY/MN (197,199 shares), BANK OF NOVA SCOTIA (88,812 shares), LPL Financial LLC (84,093 shares), UBS Group AG (59,272 shares), DOLIVER CAPITAL ADVISORS, INC. (58,141 shares), STIFEL FINANCIAL CORP (57,930 shares), FIRST TRUST ADVISORS LP (50,909 shares), and LADENBURG THALMANN FINANCIAL SERVICES INC (48,406 shares).
This table shows the top 41 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.